CIK 0000925741
- Non-accelerated filer
- Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 232753988
- Phone
- +1 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- 4 Open-market buy President and CEO bought 6,200 shares at $1.60 ($9,920)
- 4 Grant or award Senior Vice President, Devices acquired 40,490 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 61,389 shares (grant or award)
- 4 Grant or award President and CEO acquired 109,324 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4/A Grant or award President and CEO acquired 3,498 shares (grant or award)
- 4 Open-market buy President and CEO bought 100 shares at $1.87 ($187)
- 4/A Grant or award Chief Financial Officer acquired 17,347 shares (grant or award)
- 4/A Shares withheld for taxes President and CEO gave up 26,458 shares (to pay taxes)
- 4 Open-market buy 10% owner bought 595,238 shares at $1.68 ($1,000,000)
- 4 Grant or award Director acquired 148,809 shares (grant or award)
- 4 Grant or award Director acquired 148,809 shares (grant or award)
- 4 Grant or award President and CEO acquired 14,880 shares (grant or award)
- 4 Grant or award Director acquired 178,571 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 8,928 shares (grant or award)
- 4 Open-market buy President and CEO bought 4,500 shares at an average $1.87 ($8,401)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $2.07 ($4,140)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 23 · 442 filings